These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28238395)

  • 1. Profound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - A case series.
    Andonian DO; Seaman SR; Josephson EB
    Am J Emerg Med; 2017 Jun; 35(6):940.e5-940.e6. PubMed ID: 28238395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review.
    Courts J; Maskill V; Gray A; Glue P
    Australas Psychiatry; 2016 Dec; 24(6):598-601. PubMed ID: 27558216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB
    Pediatr Emerg Care; 2012 Oct; 28(10):985-9. PubMed ID: 23023462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
    Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
    Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.
    Monte AA; Calello DP; Gerona RR; Hamad E; Campleman SL; Brent J; Wax P; Carlson RG;
    J Med Toxicol; 2017 Jun; 13(2):146-152. PubMed ID: 28397128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe bradycardia and prolonged hypotension in ciguatera.
    Chan TY
    Singapore Med J; 2013 Jun; 54(6):e120-2. PubMed ID: 23665698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-headedness and bradycardia in a 72-year-old woman.
    Patel B; Wiemann C; Shah DP
    Cleve Clin J Med; 2015 May; 82(5):280-2. PubMed ID: 25973873
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.
    Hermanns-Clausen M; Kithinji J; Spehl M; Angerer V; Franz F; Eyer F; Auwärter V
    Drug Test Anal; 2016 Oct; 8(10):1030-1038. PubMed ID: 26768345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic yield of continuous video electroencephalography for paroxysmal vital sign changes in pediatric patients.
    Dang LT; Shellhaas RA
    Epilepsia; 2016 Feb; 57(2):272-8. PubMed ID: 26660005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute intoxication caused by a synthetic cannabinoid in two adolescents.
    Heath TS; Burroughs Z; Thompson AJ; Tecklenburg FW
    J Pediatr Pharmacol Ther; 2012 Apr; 17(2):177-81. PubMed ID: 23118671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sudden bradycardia and hypotension in five patients under spinal anesthesia during transurethral resection of the prostate].
    Kawasaki K; Hoshino K; Takahashi M; Ogawa S
    Masui; 2002 Sep; 51(9):992-5. PubMed ID: 12382388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
    Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
    JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard].
    Bonnet U; Mahler H
    Fortschr Neurol Psychiatr; 2015 Apr; 83(4):221-31. PubMed ID: 25893495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradycardia and hypotension after synthetic cannabinoid use: a case series.
    Kane EM; Hinson JS; Jordan CD; Paziana K; Sauber NJ; Rothman RE; Stolbach AI
    Am J Emerg Med; 2016 Oct; 34(10):2055.e1-2055.e2. PubMed ID: 27037136
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal.
    Cooper ZD
    Curr Psychiatry Rep; 2016 May; 18(5):52. PubMed ID: 27074934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.